Literature DB >> 29569804

In Vitro Fusion of Normal and Neoplastic Breast Epithelial Cells with Human Mesenchymal Stroma/Stem Cells Partially Involves Tumor Necrosis Factor Receptor Signaling.

Catharina Melzer1, Juliane von der Ohe1, Ralf Hass1.   

Abstract

Formation of hybrid cells by "accidental cell fusion" of normal and neoplastic breast epithelial cells with local tissue-associated mesenchymal stroma/stem-like cells (MSC) in an inflammatory microenvironment can generate new cancer cell populations whereby molecular signaling mechanisms of this process remain unclear. Fusions of lentiviral enhanced green fluorescent protein-labeled MSC with mcherry-labeled breast epithelial cells were quantified and effects of tumor necrosis factor alpha (TNF-α) and receptor downstream signaling were investigated. Cocultures of MSC with normal human mammary epithelial cells, with neoplastic MCF10A, or with MDA-MB-231 or MCF7 breast cancer cells demonstrated hybrid cell formation between 0.1% and about 2% of the populations within 72 hours, whereby the fusion process occurred in less than 5 minutes. Addition of the pro-inflammatory cytokine TNF-α significantly enhanced MCF10A-MSC cell fusion. Small-interfering RNA (siRNA) knockdown experiments revealed an involvement of tumor necrosis factor (TNF) receptor-1 and -2 in this process. This was also substantiated by siRNA knockdown of tumor necrosis factor receptor type 1-associated death domain which abolished TNF-α-stimulated fusion. While TNF receptor signaling can be relayed via the Mitogen-activated protein kinase 8 (MAPK8), NF-κB or cell death pathways, examination of further downstream signaling exhibited little if any effects of MAPK8 or RelA (p65) on TNF-α-mediated cell fusion, respectively. These data suggested that cell fusion between MSC and MCF10A breast epithelial cells can be stimulated by TNF-α involving TNF receptor-activated cell death pathways or additional NF-κB signaling. Stem Cells 2018;36:977-989. © AlphaMed Press 2018.

Entities:  

Keywords:  Breast and ovarian cancer; Hybrid cells; Mesenchymal stem cells; Tumor microenvironment; Tumor necrosis factor receptor

Mesh:

Substances:

Year:  2018        PMID: 29569804     DOI: 10.1002/stem.2819

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

Review 1.  Cell fusion in cancer hallmarks: Current research status and future indications.

Authors:  Hao-Fei Wang; Wei Xiang; Bing-Zhou Xue; Yi-Hao Wang; Dong-Ye Yi; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Oncol Lett       Date:  2021-05-16       Impact factor: 2.967

2.  MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Cell Commun Signal       Date:  2018-10-13       Impact factor: 5.712

Review 3.  Cell Fusion in Human Cancer: The Dark Matter Hypothesis.

Authors:  Julian Weiler; Thomas Dittmar
Journal:  Cells       Date:  2019-02-07       Impact factor: 6.600

4.  Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells.

Authors:  Catharina Melzer; Vanessa Rehn; Yuanyuan Yang; Heike Bähre; Juliane von der Ohe; Ralf Hass
Journal:  Cancers (Basel)       Date:  2019-06-09       Impact factor: 6.639

Review 5.  Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation.

Authors:  Ralf Hass; Juliane von der Ohe; Hendrik Ungefroren
Journal:  Cancers (Basel)       Date:  2019-09-25       Impact factor: 6.639

Review 6.  Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness.

Authors:  Ralf Hass; Juliane von der Ohe; Hendrik Ungefroren
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

Review 7.  The Intimate Relationship Among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes.

Authors:  Ralf Hass; Juliane von der Ohe; Hendrik Ungefroren
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

Review 8.  Cell Fusion-Mediated Tissue Regeneration as an Inducer of Polyploidy and Aneuploidy.

Authors:  Jessica Dörnen; Mareike Sieler; Julian Weiler; Silvia Keil; Thomas Dittmar
Journal:  Int J Mol Sci       Date:  2020-03-06       Impact factor: 5.923

Review 9.  Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

10.  Anti-Tumor Effects of Exosomes Derived from Drug-Incubated Permanently Growing Human MSC.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.